Asian Americans generally have lower cancer rates than the total population. However, health gaps still exist within certain types of cancer.1
- From 2019-2023,2
- Death rates for stomach cancer in Asian/Pacific Islander males exceeded the total male population by 49%.
- Asian/Pacific Islander females died from liver and IBD cancer and from stomach cancer at rates 21% and 65% higher, respectively, than females in the total population.
- In 2022, Asian/Pacific Islanders, both male and female, had rates of new liver and intrahepatic bile duct (IBD) cancer that were 19% higher than those in their respective total populations.
Visit MedlinePlus for more health information about Cancer and Living with Cancer in multiple Asian languages.
Visit the Centers for Disease Control and Prevention and the National Cancer Institute for information about cancer screening.
Looking for curated searches on cancer within minority and tribal populations, including Asian American populations, in the United States and its territories? Check out the OMH Knowledge Center Topic Guides.
Occurrence
| Cancer among adults ages 18 and over, age-adjusted percentage, 2024 | |||
|---|---|---|---|
| Cancer | Asian | Total Population | Ratio (Asian / Total) |
| All Sites | 5.1 | 10.3 | 0.50 |
| Breast | 1.3 | 1.8 | 0.72 |
| Cervical (Females) | 0.2 | 0.7 | 0.29 |
| Prostate (Males) | 2.0 | 2.6 | 0.77 |
| Any skin | 0.2 | 3.6 | 0.06 |
Top Cancer Sites
| Cancer incidence among males, delay-adjusted and age-adjusted rate per 100,000 population, 2022 | |||
|---|---|---|---|
| Cancer | Asian/Pacific Islander* Males | Total Population Males | Ratio (Asian/Pacific Islander* / Total) |
| All Sites | 328.3 | 500.3 | 0.66 |
| Colon & Rectum (Including Appendix) | 38.3 | 43.5 | 0.88 |
| Esophagus | 4.1 | 7.3 | 0.56 |
| Kidney | 11.7 | 23.6 | 0.50 |
| Liver & Intrahepatic Bile Duct (IBD) | 16.6 | 13.9 | 1.19 |
| Lung | 41.2 | 51.0 | 0.81 |
| Oral Cavity & Pharynx | 12.3 | 17.9 | 0.69 |
| Pancreas | 12.1 | 15.9 | 0.76 |
| Prostate | 77.2 | 133.6 | 0.58 |
| Stomach | 12.3 | 9.6 | 1.28 |
| Cancer incidence among females, delay-adjusted and age-adjusted rate per 100,000 population, 2022 | |||
|---|---|---|---|
| Cancer | Asian/Pacific Islander* Females | Total Population Females | Ratio (Asian/Pacific Islander / Total) |
| All Sites | 349.0 | 441.7 | 0.79 |
| Breast | 126.9 | 136.5 | 0.93 |
| Cervical | 5.8 | 7.8 | 0.74 |
| Colon & Rectum (Including Appendix) | 27.1 | 34.0 | 0.80 |
| Kidney | 5.3 | 12.0 | 0.44 |
| Liver & Intrahepatic Bile Duct (IBD) | 6.9 | 5.8 | 1.19 |
| Lung | 28.5 | 43.7 | 0.65 |
| Pancreas | 9.9 | 12.7 | 0.78 |
| Stomach | 7.6 | 6.5 | 1.17 |
| Uterus | 24.7 | 29.2 | 0.85 |
Five-Year Survival Rates
| 5-year survival rate among males, percentage, 2015–2021 | |||
|---|---|---|---|
| Cancer | Asian/Pacific Islander* Males | Total Population Males | Ratio (Asian/Pacific Islander* / Total) |
| All Sites | 62.2 | 68.7 | 0.91 |
| Colon & Rectum (Including Appendix) | 66.9 | 64.5 | 1.04 |
| Kidney | 79.3 | 78.8 | 1.01 |
| Liver & IBD | 31.2 | 21.7 | 1.44 |
| Lung | 29.3 | 23.8 | 1.23 |
| Pancreas | 14.6 | 13.1 | 1.11 |
| Prostate | 93.8 | 98.6 | 0.95 |
| Stomach | 42.9 | 34.2 | 1.25 |
| 5-year survival rate among females, percentage, 2015–2021 | |||
|---|---|---|---|
| Cancer | Asian/Pacific Islander* Females | Total Population Females | Ratio (Asian/Pacific Islander* / Total) |
| All Sites | 73.3 | 71.2 | 1.03 |
| Breast | 92.3 | 91.7 | 1.01 |
| Cervical | 70.9 | 68.0 | 1.04 |
| Colon & Rectum (Including Appendix) | 66.9 | 66.4 | 1.01 |
| Kidney | 80.0 | 81.4 | 0.98 |
| Liver & IBD | 28.2 | 22.8 | 1.24 |
| Lung | 40.1 | 32.6 | 1.23 |
| Pancreas | 15.5 | 13.5 | 1.15 |
| Stomach | 42.0 | 43.2 | 0.97 |
| Uterus | 82.3 | 81.1 | 1.01 |
Mortality
| 5-year mortality among males, age-adjusted rate per 100,000 population, 2019–2023 | |||
|---|---|---|---|
| Cancer | Asian/Pacific Islander* Males | Total Population Males | Ratio (Asian/Pacific Islander / Total) |
| All Sites | 107.1 | 171.5 | 0.62 |
| Colon & Rectum (Including Appendix) | 10.9 | 15.3 | 0.71 |
| Liver & IBD | 11.4 | 9.4 | 1.21 |
| Lung | 23.4 | 37.2 | 0.63 |
| Pancreas | 8.4 | 12.9 | 0.65 |
| Prostate | 8.8 | 19.2 | 0.46 |
| Stomach | 5.2 | 3.5 | 1.49 |
| 5-year mortality among females, age-adjusted rate per 100,000 population, 2019–2023 | |||
|---|---|---|---|
| Cancer | Asian/Pacific Islander* Females | Total Population Females | Ratio (Asian/Pacific Islander* / Total) |
| All Sites | 83.1 | 126.3 | 0.66 |
| Breast | 11.8 | 19.2 | 0.61 |
| Cervical | 1.6 | 2.2 | 0.73 |
| Colon & Rectum (Including Appendix) | 7.8 | 10.8 | 0.72 |
| Liver & IBD | 5.2 | 4.3 | 1.21 |
| Pancreas | 7.2 | 9.9 | 0.73 |
| Stomach | 3.3 | 2.0 | 1.65 |
| Uterus | 3.8 | 5.3 | 0.72 |
Health Care Use
| Females ages 40 and over who had a mammogram within the past 2 years, crude percentage, 2019 | ||
|---|---|---|
| Asian* Females | Total Population Females | Ratio (Asian* / Total) |
| 63.7 | 79.8 | 0.80 |
| Females aged 21 to 65 years receiving a cervical cancer screening based on the most recent guidelines, percentage, 2021 | ||
|---|---|---|
| Asian* Females | Total Population Females | Ratio (Asian* / Total) |
| 62.7 | 73.9 | 0.85 |
| Adults aged 45 to 75 years receiving a colorectal cancer screening based on the most recent guidelines, percentage, 2023 | ||
|---|---|---|
| Asian* | Total Population | Ratio (Asian* / Total) |
| 57.0 | 63.5 | 0.90 |
*Population is non-Hispanic in the data source.
1 SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. (Back to top)
2 SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. (Back to top)
Date Last Reviewed: January 2026
